BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12874072)

  • 1. Prevalence of nodal metastases in the submuscular recess (level IIb) during selective neck dissection.
    Silverman DA; El-Hajj M; Strome S; Esclamado RM
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):724-8. PubMed ID: 12874072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodal metastases at level IIb during neck dissection for head and neck cancer: clinical and pathologic evaluation.
    Santoro R; Franchi A; Gallo O; Burali G; de' Campora E
    Head Neck; 2008 Nov; 30(11):1483-7. PubMed ID: 18798305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Level IIb lymph node metastasis in laryngeal squamous cell carcinoma.
    Lim YC; Lee JS; Koo BS; Choi EC
    Laryngoscope; 2006 Feb; 116(2):268-72. PubMed ID: 16467717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic metastases to level IIb in hypopharyngeal squamous cell carcinoma.
    Kim YH; Koo BS; Lim YC; Lee JS; Kim SH; Choi EC
    Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1060-4. PubMed ID: 17043251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentric prospective study on the prevalence of sublevel IIb metastases in head and neck cancer.
    Villaret AB; Piazza C; Peretti G; Calabrese L; Ansarin M; Chiesa F; Pellini R; Spriano G; Nicolai P
    Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):897-903. PubMed ID: 17875856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic effectiveness of selective neck dissection in the N0 irradiated neck.
    Solares CA; Fritz MA; Esclamado RM
    Head Neck; 2005 May; 27(5):415-20. PubMed ID: 15712298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
    Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
    Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective neck dissection for node-positive necks in patients with head and neck squamous cell carcinoma: a word of caution.
    Santos AB; Cernea CR; Inoue M; Ferraz AR
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):79-81. PubMed ID: 16415434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level V lymph node dissection in oral and oropharyngeal carcinoma patients with clinically node-positive neck: is it absolutely necessary?
    Lim YC; Koo BS; Lee JS; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1232-5. PubMed ID: 16826066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of immunohistochemically demonstrated nodal micrometastases in patients with squamous cell carcinoma of the head and neck.
    Rhee D; Wenig BM; Smith RV
    Laryngoscope; 2002 Nov; 112(11):1970-4. PubMed ID: 12439164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is dissection of level IV absolutely necessary in elective lateral neck dissection for clinically N0 laryngeal carcinoma?
    Lim YC; Choi EC; Lee JS; Koo BS; Song MH; Shin HA
    Oral Oncol; 2006 Jan; 42(1):102-7. PubMed ID: 16143563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective neck dissection in the management of the clinically node-negative neck.
    Hosal AS; Carrau RL; Johnson JT; Myers EN
    Laryngoscope; 2000 Dec; 110(12):2037-40. PubMed ID: 11129016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of contralateral N0 neck in pyriform sinus carcinoma.
    Koo BS; Lim YC; Lee JS; Kim YH; Kim SH; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1268-72. PubMed ID: 16826073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical treatment of neck lymph nodes in squamous cell carcinoma of the pyriform sinus].
    De Zinis LO; Cavalleri M; Casirati C; Nicolai P; Antonelli AR
    Acta Otorhinolaryngol Ital; 2001 Dec; 21(6):341-9. PubMed ID: 11938706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma.
    Gourin CG; Conger BT; Porubsky ES; Sheils WC; Bilodeau PA; Coleman TA
    Laryngoscope; 2008 Jul; 118(7):1191-4. PubMed ID: 18391764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
    Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.
    Schöder H; Carlson DL; Kraus DH; Stambuk HE; Gönen M; Erdi YE; Yeung HW; Huvos AG; Shah JP; Larson SM; Wong RJ
    J Nucl Med; 2006 May; 47(5):755-62. PubMed ID: 16644744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of metastatic lymph node topography in head and neck squamous cell carcinomas.
    Tao L; Lefèvre M; Callard P; Périé S; Bernaudin JF; St Guily JL
    Otolaryngol Head Neck Surg; 2006 Sep; 135(3):445-50. PubMed ID: 16949980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma from an unknown head and neck primary site: a "selective treatment" approach.
    Patel RS; Clark J; Wyten R; Gao K; O'Brien CJ
    Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1282-7. PubMed ID: 18086973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perifacial lymph node metastasis in the submandibular triangle of patients with oral and oropharyngeal squamous cell carcinoma with clinically node-positive neck.
    Lim YC; Lee JS; Choi EC
    Laryngoscope; 2006 Dec; 116(12):2187-90. PubMed ID: 17146394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.